Your shopping cart is currently empty

SR-3-65 (compound 6) is an Indisulam derivative that inhibits the migration of gastric cancer cells by weakening the PI3K/AKT/GSK-3β/β-catenin signaling pathway.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | SR-3-65 (compound 6) is an Indisulam derivative that inhibits the migration of gastric cancer cells by weakening the PI3K/AKT/GSK-3β/β-catenin signaling pathway. |
| In vitro | SR-3-65 effectively inhibits the growth of AGS cells with an IC₅₀ value of 24.75 μM when administered at concentrations ranging from 0.0001-100 µM over a 48-hour period. Additionally, SR-3-65 at 10 µM demonstrates anti-migratory activity in AGS and MGC803 cells over 48-72 hours. Furthermore, in AGS and MGC803 cells treated with 10 µM SR-3-65 for 48 hours, there is an upregulation of E-cadherin and a downregulation of N-cadherin and vimentin expression. |
| Formula | C16H9ClF3N3O2S |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.